Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$0.00 – $0.09
10% from low
Exchange
OTC Link
CS
Borrow rate
0.25%
Easy to borrow
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $12.9K | $12.2K | $10.2K | $7.6K | $2.2K | $10.0K | $0 | $0 |
| Cost of revenue | $0 | $0 | $2.6K | $0 | $952 | $3.8K | $5.0K | $5.0K |
| Gross profit | $12.9K | $12.2K | $7.6K | $7.6K | $1.3K | $6.2K | −$5.0K | −$5.0K |
| Gross margin | 100.0% | 100.0% | 74.2% | 100.0% | 57.4% | 61.9% | — | — |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | −$7.3K | −$15.2K | −$158.1K | −$32.7K | −$17.8K | −$8.5K | −$30.0K | −$20.8K |
| EBITDA | −$6.7K | −$14.3K | −$994.2K | −$119.7K | −$15.9K | $429.9K | −$25.0K | −$15.8K |
| Net income | −$7.3K | −$15.2K | −$498.6K | −$60.4K | −$8.4K | $426.9K | −$15.0K | −$10.4K |
| Net margin | -56.4% | -124.9% | -4891.3% | -798.0% | -376.9% | 4269.1% | — | — |
| EPS (diluted) | -0.00 | -0.00 | -0.03 | -0.00 | -0.00 | 0.02 | -0.00 | 0.00 |
Annual figures · source: Financial Modeling Prep
THC FARMACEUTICALS INC
No one on the platform currently holds CBDG.
No tracked institution reports a position in CBDG as of their last filing.
No one on the platform has traded CBDG yet.
| $66716 |
| — |
| RASPActavia Life Sciences, Inc. | $0.00 | +0.00% | $385906 | — |
| RGBPRegen BioPharma, Inc. | $0.00 | -50.00% | $3155 | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.